96 related articles for article (PubMed ID: 10853422)
1. [The radiosensitizer AK-2123 enhances sensitivity of MDR-tumors to Mitomycin C].
Goncharova SA; Raevskaia TA; Konovalova NP; Kagiia VT
Vopr Onkol; 2000; 46(2):202-8. PubMed ID: 10853422
[TBL] [Abstract][Full Text] [Related]
2. Nitrotriazole AK-2123 enhances mitomycin C activity in mice bearing multidrug-resistant tumors.
Goncharova SA; Rajewskaya TA; Konovalova NP; Kagiya TV
J Chemother; 2001 Dec; 13(6):635-40. PubMed ID: 11806625
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of radiosensitizer AK-2123 on experimental hepatic metastases and Ca2+ active transport.
Konovalova NP; Volkova LM; Tatyanenko LV; Kotelnikova RA; Yakushchenko TN; Kagiya TV
Neoplasma; 1997; 44(6):361-5. PubMed ID: 9605008
[TBL] [Abstract][Full Text] [Related]
4. In vivo characterization of P388 leukemia resistant to mitomycin C.
Rose WC; Huftalen JB; Bradner WT; Schurig JE
In Vivo; 1987; 1(1):47-52. PubMed ID: 2979764
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of the radiosensitizer AK-2123 on experimental liver metastasis and active transport of calcium ions].
Konovalova NP; Volkova LM; Tat'ianenko LV; Kotel'nikova RA; Iakushchenko TN; Kagiia T
Vopr Onkol; 1997; 43(3):309-12. PubMed ID: 9245088
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.
Konovalova NP; Diatchkovskaya RF; Volkova LM; Kagiya TV
Neoplasma; 1995; 42(3):119-22. PubMed ID: 7637820
[TBL] [Abstract][Full Text] [Related]
7. Modification of radio-thermo-chemotherapy by AK-2123 and hydralazine in tumor bearing mice.
Kunugita N; Mei N; Norimura T; Kagiya TV
Indian J Exp Biol; 1996 Sep; 34(9):838-41. PubMed ID: 9014514
[TBL] [Abstract][Full Text] [Related]
8. [Sensitivity to chemotherapeutic preparations of anthracycline-resistant strains of murine leukemia P388].
Demidova NS; Goncharova SA; Shiriaeva OA; Konovalova NP
Eksp Onkol; 1989; 11(1):65-8. PubMed ID: 2924713
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
10. Does AK-2123 (Senazole) have sensitizing effects on radiation, cisplatin and hyperthermia under aerobic conditions in vitro?
Mitsuhashi N; Sakurai H; Takahashi T; Akimoto T; Higuchi K; Matsumoto H; Ebara T; Nozaki M; Niibe H
Anticancer Res; 1998; 18(5A):3463-7. PubMed ID: 9858925
[TBL] [Abstract][Full Text] [Related]
11. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
[TBL] [Abstract][Full Text] [Related]
12. Decreased sensitivity of multidrug-resistant tumor cells to cisplatin is correlated with sorcin gene co-amplification.
Demidova NS; Ilyinskaya GV; Shiryaeva OA; Chernova OB; Goncharova SA; Kopnin BP
Neoplasma; 1995; 42(4):195-201. PubMed ID: 7659186
[TBL] [Abstract][Full Text] [Related]
13. Phosphorus-containing metabolites in anthracycline-resistant murine leukemia P388 cells.
Shiryaeva OA; Semenova NA; Sibeldina LA; Goncharova SA; Konovalova NP
Neoplasma; 1992; 39(4):229-32. PubMed ID: 1436233
[TBL] [Abstract][Full Text] [Related]
14. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K
Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484
[TBL] [Abstract][Full Text] [Related]
15. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
Donenko FV; Sitdikova SM; Kabieva AO
Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
[TBL] [Abstract][Full Text] [Related]
16. [Synergistic antitumor effect of sodium caffeate and mitomycin].
Xu F; Song DQ; Zhen YS
Yao Xue Xue Bao; 2002 Jun; 37(6):405-8. PubMed ID: 12579792
[TBL] [Abstract][Full Text] [Related]
17. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.
Marchini S; Damia G; Broggini M; Pennella G; Ripamonti M; Marsiglio A; Geroni C
Cancer Res; 2001 Mar; 61(5):1991-5. PubMed ID: 11280757
[TBL] [Abstract][Full Text] [Related]
18. Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C.
Xin Y; Lyness G; Chen D; Song S; Wientjes MG; Au JL
J Urol; 2005 Jul; 174(1):322-7. PubMed ID: 15947683
[TBL] [Abstract][Full Text] [Related]
19. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
[TBL] [Abstract][Full Text] [Related]
20. Vitamins B6 and C and mitomycin C-efficiency under irradiation.
Svoboda B; Getoff N
Anticancer Res; 2002; 22(2A):949-52. PubMed ID: 12014677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
